Logo

Call us today 212-583-0100

ir@enzo.com    

  • Home
  • Corporate
    • Investor Information
    • About Us
    • Officers & Directors
    • Press Releases
    • Careers
  • Therapeutics
    • About ENZO Therapeutics
      • Overview
      • Our Mission
      • Our Strategy
      • Partnering
      • Maps and Directions
      • Contact Us
    • Therapeutic Market
      • Overview
      • Inflammatory Bowel Disease
      • Uveitis
      • HIV
      • Bone Disorders
      • Diabetes
    • Technologies
      • Immune Regulation
      • Gene Technology
      • Cell Signaling Modulation
    • Pipeline
      • Overview
      • Cell Signaling Modulation
        • Diabetes
        • Preclinical Studies for Bone Disorders
      • Immune Regulation
        • Alequel ™
        • Optiquel ™
      • Gene Technology
        • Stealth Vector™ HGTV43™
  • Clinical Labs
  • Life Sciences
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 06, 2022 8:30am EDT

UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

Jun 02, 2022 5:05pm EDT

Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

Apr 19, 2022 8:00am EDT

Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test

Apr 12, 2022 8:30am EDT

Enzo Biochem Reports Results of its Annual Meeting of Shareholders

Apr 06, 2022 4:57pm EDT

Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal

Apr 01, 2022 8:00am EDT

Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022

Mar 28, 2022 4:17pm EDT

Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions

Mar 14, 2022 4:10pm EDT

Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates

Mar 10, 2022 8:37am EST

Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

Mar 08, 2022 8:29am EST

Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …33
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Meta

  • Privacy Policy
  • Intellectual Property
  • Safe Harbor Statement
  • HIPAA Policy
  • Web Feedback

Contact us

Enzo Biochem Executive Offices
81 Executive Blvd, Suite 3
Farmingdale, NY
11735
USA

212-583-0100

info@enzo.com

Copyright ©2023 Enzo Biochem Inc.